Immunotherapy in elderly patients (≥ 75 yrs) with advanced non-small cell lung cancer (NSCLC): A multicenter Italian experience

被引：0
|
作者：
Luciani, A. [1 ]
Toschi, L. [2 ]
Fava, S. [3 ]
Cortinovis, D. [4 ]
Filipazzi, V. [5 ]
Tuzi, A. [6 ]
Marra, A. [1 ]
Rossi, S. [2 ]
Rossi, A. [7 ]
Blasi, M. [1 ]
Violati, M. [1 ]
Sala, L. [4 ]
Agustoni, F. [4 ]
Bidoli, P. [4 ]
Zonato, S. [1 ]
Ferrari, D. [1 ]
机构：
[1] Azienda Osped S Paolo, Med Oncol, Milan, Italy
[2] Ist Clin Humanitas, Med Oncol, Rozzano, Italy
[3] Osped Civile Legnano, Med Oncol, Legnano, Italy
[4] Azienda Osped S Gerardo, UO Oncol Med, Med Oncol, Monza, Italy
[5] Osped L Sacco, Med Oncol, Milan, Italy
[6] Osped Circolo Fdn Macchi, Med Oncol, Varese, Italy
[7] IRCCS Casa Sollievo Sofferenza, Med Oncol, San Giovanni Rotondo, Italy
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1472P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [32] Immunotherapy Beyond Progression for Patients with Advanced Non-Small Cell Lung Cancer
    Ge, X.
    Zhang, Z.
    Yan, X.
    Zhang, F.
    Yuan, F.
    Han, X.
    Huang, Z.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Zhi, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S641 - S642
  • [33] The use of immunotherapy in older patients with advanced non-small cell lung cancer
    Tagliamento, Marco
    Frelaut, Maxime
    Baldini, Capucine
    Naigeon, Marie
    Nencioni, Alessio
    Chaput, Nathalie
    Besse, Benjamin
    CANCER TREATMENT REVIEWS, 2022, 106
  • [34] Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
    Ge, Xiangwei
    Zhang, Zhibo
    Zhang, Sujie
    Yuan, Fang
    Zhang, Fan
    Yan, Xiang
    Han, Xiao
    Ma, Junxun
    Wang, Lijie
    Tao, Haitao
    Li, Xiaoyan
    Zhi, Xiaoyu
    Huang, Zhiyue
    Hofman, Paul
    Prelaj, Arsela
    Banna, Giuseppe Luigi
    Mutti, Luciano
    Hu, Yi
    Wang, Jinliang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2391 - 2400
  • [35] Palliative chemotherapy (QT) and prognostic factors in elderly patients with advanced non-small Cell lung cancer (NSCLC)
    Zotano, AG
    Ariño, LP
    Saera, JM
    Abad, LP
    Lorenzo, JP
    Ortiz, AG
    Beveridge, RD
    Huerta, AS
    Salcedo, JM
    LUNG CANCER, 2005, 49 : S246 - S246
  • [36] Weekly Paclitaxel as Third Line Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
    Belloni, P.
    Cozzi, C.
    Zannier, F.
    Corradini, G.
    Candido, P.
    Della Torre, S.
    Toniolo, D.
    Fariciotti, A.
    Vismara, A.
    Bollina, R.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S538 - S538
  • [37] Is the platinum-based chemotherapy necessary for elderly patients with advanced non-small cell lung cancer (NSCLC)?
    Daga, H.
    Takeda, K.
    Kiyota, H.
    Tokunaga, S.
    Nanjo, S.
    Sumitani, M.
    Shoji, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] ACTIVE IMMUNOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER
    Neninger, Elia
    Camilo Rodriguez, Pedro
    Crombet, Tania
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S194 - S194
  • [39] Personalized immunotherapy for advanced non-small cell lung cancer
    Herbst, Roy S.
    ANNALS OF ONCOLOGY, 2015, 26 : 16 - 16
  • [40] Treatment Options in Advanced Non-Small Cell Lung Cancer (NSCLC) in the Elderly: An Evolving Landscape
    Langer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1651 - S1652
12345